Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: Anthony@Pacific who wrote (52627)	3/6/2000 6:09:00 PM
From: Oleg Sogolov	Respond to of 122087

Is Priceline ripe for shorting yet? Closed up $15+ and up $5+ AH.

To: Anthony@Pacific who wrote (52627)	3/6/2000 6:11:00 PM
From: Anthony@Pacific	Read Replies (1) \| Respond to of 122087

NERX<-------Todays News is one month old, released last month!!!! in the Med journal!

To: Anthony@Pacific who wrote (52627)	3/6/2000 11:53:00 PM
From: wallstreeter	Respond to of 122087

hello anthony,avxt has a human cancer vaccine that is ready for commercialization in autralia,new zealand,germany and japan,and it will be shipped to australia this year for commercialization ( a historic first). check their excellent 9 year follow up data, 55% of patients survived 5 or more years compared to the standard 22%. its at 14.5 which is what i cant believe when i see a stock like nerx curing cancer in mice. avxt has a human cancer vaccine ready formarket use. any of your comments would be welcomed anthony. wallstreeterww